{"nct_id":"NCT03269695","title":"Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.","status":"TERMINATED","status_verified_date":"2021-11","start_date":"2017-12-20","start_date_type":"ACTUAL","primary_completion_date":"2021-01-07","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}